Search research articles
Contact Us
Filters
Showing results (231-240 of 251) with videos related to
Page
of 26
Sort By:
Journal of the National Cancer Institute
|
September 5, 1990
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma
E R Gaynor, G R Weiss, K A Margolin, et al.
Cellular and Molecular Bioengineering
|
October 9, 2023
Amelioration of Subglottic Stenosis by Antimicrobial Peptide Eluting Endotracheal Tubes
Matthew R Aronson, Amrita Mehta, Ryan M Friedman, et al.
Journal of Community Psychology
|
February 24, 2021
The interaction of exposure to adverse childhood and combat experiences on the current mental health of new post-9/11 veterans
Nicole R Morgan, Keith R Aronson, Daniel F Perkins, et al.
Viruses
|
July 2, 2021
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies
Dan Liu, Jonas D Van Belleghem, Christiaan R de Vries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1990
Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells
M H Bar, M Sznol, M B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1992
A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma
G R Weiss, K A Margolin, F R Aronson, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1994
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors
J A Sparano, R I Fisher, G R Weiss, et al.
International Journal for Educational and Vocational Guidance
|
February 23, 2022
The influence of employment program components upon job attainment during a time of identity and career transition
Daniel F Perkins, Katie E Davenport, Nicole R Morgan, et al.
American Journal of Hematology
|
August 1, 1987
Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2
F R Aronson, R A Dempsey, M Allegretta, et al.
Plos One
|
February 26, 2020
Discovery of antitumor lectins from rainforest tree root transcriptomes
Atip Lawanprasert, Caitlin A Guinan, Erica A Langford, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 251) with videos related to
Sort By:
Page
of 26
Journal of the National Cancer Institute
|
September 5, 1990
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma
E R Gaynor, G R Weiss, K A Margolin, et al.
Cellular and Molecular Bioengineering
|
October 9, 2023
Amelioration of Subglottic Stenosis by Antimicrobial Peptide Eluting Endotracheal Tubes
Matthew R Aronson, Amrita Mehta, Ryan M Friedman, et al.
Journal of Community Psychology
|
February 24, 2021
The interaction of exposure to adverse childhood and combat experiences on the current mental health of new post-9/11 veterans
Nicole R Morgan, Keith R Aronson, Daniel F Perkins, et al.
Viruses
|
July 2, 2021
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies
Dan Liu, Jonas D Van Belleghem, Christiaan R de Vries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1990
Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells
M H Bar, M Sznol, M B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1992
A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma
G R Weiss, K A Margolin, F R Aronson, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1994
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors
J A Sparano, R I Fisher, G R Weiss, et al.
International Journal for Educational and Vocational Guidance
|
February 23, 2022
The influence of employment program components upon job attainment during a time of identity and career transition
Daniel F Perkins, Katie E Davenport, Nicole R Morgan, et al.
American Journal of Hematology
|
August 1, 1987
Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2
F R Aronson, R A Dempsey, M Allegretta, et al.
Plos One
|
February 26, 2020
Discovery of antitumor lectins from rainforest tree root transcriptomes
Atip Lawanprasert, Caitlin A Guinan, Erica A Langford, et al.
Page
of 26